Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Week in Review: FDA's new safety warning | J&J considering a sale | AVR recommended for asymptomatic severe AS | Much more
Saturday, February 15, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

FDA warns that atherectomy devices are breaking during use—30 serious injuries, 4 deaths reported

More than 100 incidents have been reported so far. The FDA is still evaluating this issue, but the agency wanted to raise awareness as quickly as possible.

READ MORE >
The U.S. Food and Drug Administration (FDA) has shared a new warning about ongoing safety issues with atherectomy devices sold and distributed by Bard Peripheral Vascular, an Arizona-based subsidiary of Becton, Dickinson and Company (BD). The warning includes multiple models of Bard Peripheral Vascular’s Rotarex Atherectomy System, which is designed to target high-risk plaques and blood clots in the peripheral arteries by rotating at a high speed.
Share on Twitter Share on Facebook Share on Linkedin

FDA warns that atherectomy devices are breaking during use—30 serious injuries, 4 deaths reported

Share on Twitter Share on Facebook Share on Linkedin
The U.S. Food and Drug Administration (FDA) has shared a new warning about ongoing safety issues with atherectomy devices sold and distributed by Bard Peripheral Vascular, an Arizona-based subsidiary of Becton, Dickinson and Company (BD). The warning includes multiple models of Bard Peripheral Vascular’s Rotarex Atherectomy System, which is designed to target high-risk plaques and blood clots in the peripheral arteries by rotating at a high speed.
More than 100 incidents have been reported so far. The FDA is still evaluating this issue, but the agency wanted to raise awareness as quickly as possible.
READ MORE >

Report: Johnson & Johnson wants to sell its stroke business for more than $1B

Johnson & Johnson has reportedly had early discussions with potential buyers about its Cerenovus division of stroke products.

READ MORE >
artificial intelligence money finance acquisition
Share on Twitter Share on Facebook Share on Linkedin

Report: Johnson & Johnson wants to sell its stroke business for more than $1B

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence money finance acquisition
Johnson & Johnson has reportedly had early discussions with potential buyers about its Cerenovus division of stroke products.
READ MORE >

Cardiologists recommend AVR for asymptomatic severe AS—TAVR and surgery both viable options

A trio of leading voices in cardiology reviewed years of data while considering their proposal. The choice between TAVR and SAVR, they added, should be made on a case-by-case basis.

READ MORE >
Heart cardiologists doctors surgery
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists recommend AVR for asymptomatic severe AS—TAVR and surgery both viable options

Share on Twitter Share on Facebook Share on Linkedin
Heart cardiologists doctors surgery
A trio of leading voices in cardiology reviewed years of data while considering their proposal. The choice between TAVR and SAVR, they added, should be made on a case-by-case basis.
READ MORE >

Interventional heart failure: An evolving cardiology subspecialty with a bright future

IHF cardiologists can come from a variety of backgrounds, but they all share the same goal: to ensure complex heart failure patients receive the best care possible. 

READ MORE >
female cardiologist
Share on Twitter Share on Facebook Share on Linkedin

Interventional heart failure: An evolving cardiology subspecialty with a bright future

Share on Twitter Share on Facebook Share on Linkedin
female cardiologist
IHF cardiologists can come from a variety of backgrounds, but they all share the same goal: to ensure complex heart failure patients receive the best care possible. 
READ MORE >

Physicians are leaning into supra-annular, self-expanding TAVR valves for women and small-annulus patients

Sponsored by Medtronic

"The onus is on us as cardiologists to make sure we offer the very best possible devices for our patients with the available data that we have," interventional cardiologist Anene Ukaigwe, MD, explained. 

READ MORE >
FX+ Image
Share on Twitter Share on Facebook Share on Linkedin

Physicians are leaning into supra-annular, self-expanding TAVR valves for women and small-annulus patients

Sponsored by Medtronic

Share on Twitter Share on Facebook Share on Linkedin
FX+ Image
"The onus is on us as cardiologists to make sure we offer the very best possible devices for our patients with the available data that we have," interventional cardiologist Anene Ukaigwe, MD, explained. 
READ MORE >

ASE shares new guidelines for ultrasound-guided vascular access

The American Society of Echocardiography included descriptions, diagrams and ultrasound images in the new document to make it as helpful as possible. 

READ MORE >
Figure from the new ASE guideline for ultrasound guided vascular access, showing vessel and probe orientation on the transverse plane short axis (SAX) view perpendicular to the vessels, or in longitudinal long axis plane (LAX) coaxial to the vessels. Image courtesy of ASE
Share on Twitter Share on Facebook Share on Linkedin

ASE shares new guidelines for ultrasound-guided vascular access

Share on Twitter Share on Facebook Share on Linkedin
Figure from the new ASE guideline for ultrasound guided vascular access, showing vessel and probe orientation on the transverse plane short axis (SAX) view perpendicular to the vessels, or in longitudinal long axis plane (LAX) coaxial to the vessels. Image courtesy of ASE
The American Society of Echocardiography included descriptions, diagrams and ultrasound images in the new document to make it as helpful as possible. 
READ MORE >

CABG, TAVR top list of most lucrative heart procedures for hospitals

Other procedures are associated with higher profits—heart transplants, for instance—but CABG and TAVR are performed much more often.

READ MORE >
Money dollar investments
Share on Twitter Share on Facebook Share on Linkedin

CABG, TAVR top list of most lucrative heart procedures for hospitals

Share on Twitter Share on Facebook Share on Linkedin
Money dollar investments
Other procedures are associated with higher profits—heart transplants, for instance—but CABG and TAVR are performed much more often.
READ MORE >

Final decision on the creation of a new cardiovascular board expected soon

U.S. cardiology groups have worked together to propose the creation of a new American Board of Cardiovascular Medicine for certifying cardiologists. Now, after many months of waiting, a final decision is expected by the end of February. 

READ MORE >
ACC Vice President Christopher Kramer, MD, FACC, offers an update on the creation of a new cardiovascular board.
Share on Twitter Share on Facebook Share on Linkedin

Final decision on the creation of a new cardiovascular board expected soon

Share on Twitter Share on Facebook Share on Linkedin
ACC Vice President Christopher Kramer, MD, FACC, offers an update on the creation of a new cardiovascular board.
U.S. cardiology groups have worked together to propose the creation of a new American Board of Cardiovascular Medicine for certifying cardiologists. Now, after many months of waiting, a final decision is expected by the end of February. 
READ MORE >

AI brings cardiology, neurology teams together to boost care for stroke patients

A new post-stroke care pathway from Viz.ai and Medtronic is associated with significant benefits, including higher patient and clinician satisfaction.

READ MORE >
artificial intelligence consultation
Share on Twitter Share on Facebook Share on Linkedin

AI brings cardiology, neurology teams together to boost care for stroke patients

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence consultation
A new post-stroke care pathway from Viz.ai and Medtronic is associated with significant benefits, including higher patient and clinician satisfaction.
READ MORE >

Treating a broken heart: Beta-blockers improve survival in patients with takotsubo syndrome

Takotsubo syndrome, commonly known as “broken heart syndrome,” is often treated as if it was heart failure, but the optimal clinical approach remains a bit of a mystery.

READ MORE >
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
Share on Twitter Share on Facebook Share on Linkedin

Treating a broken heart: Beta-blockers improve survival in patients with takotsubo syndrome

Share on Twitter Share on Facebook Share on Linkedin
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
Takotsubo syndrome, commonly known as “broken heart syndrome,” is often treated as if it was heart failure, but the optimal clinical approach remains a bit of a mystery.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup